SENSEX: 72,400 ▲ 0.5% NIFTY: 21,800 ▲ 0.4% GOLD: 62,500 ▼ 0.2%
AlphaStreet Analysis

J B Chemicals Q3 FY26 Earnings Results

J.B. Chemicals and Pharmaceuticals Limited, established in 1976, is one of India’s leading pharmaceutical companies. An integrated, publicly-listed organization with a focus on supplying affordable, quality products both in India and internationally, JBCPL is trusted by healthcare professionals globally.

Financial Results

J B Chemicals & Pharmaceuticals Ltd reported Revenues for Q3FY26 of ₹1,065.00 Crores up from ₹963.00 Crore year on year, a rise of 10.59%.

Total Expenses for Q3FY26 of ₹816.00 Crores up from ₹754.00 Crores year on year, a rise of 8.22%.

Consolidated Net Profit of ₹198.00 Crores up 22.22% from ₹162.00 Crores in the same quarter of the previous year.

The Earnings per Share is ₹12.63, up 20.86% from ₹10.45 in the same quarter of the previous year.